Working… Menu

Phase 2 Tolerability and Effects of ALK-001 on Stargardt Disease (TEASE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02402660
Recruitment Status : Recruiting
First Posted : March 30, 2015
Last Update Posted : May 5, 2020
Information provided by (Responsible Party):
Alkeus Pharmaceuticals, Inc.